PROJECT STEEL ACQUIRECO LIMITED
Company number SC780681 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£10,208,389
Balance sheet as at 2025-12-31
What it does
Project Steel Acquireco Limited is a holding company having acquired in October 2023, the share capital of RoukenBio (trading name of Antibody Analytics Limited) which is a specialist CRO providing immunology and bioassay services to global clients in preclinical drug development. Our focus areas include inflammation, autoimmune disorders, immuno-oncology, and oncology.
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2023-08-29
- Employees
- 108 (2025 accounts · was 101 in 2024)
- Registered office
- Rouken Discovery Centre, Braidhurst Industrial Estate, Motherwell, North Lanarkshire, Scotland, ML1 3ST
- Postcode
- ML1 3ST
- Capital
- 102 GBP
- Accounts category
- Group
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-08-25
- Next due by
- 2027-09-08
Nature of business (SIC)
- 74909 Other professional, scientific and technical activities not elsewhere classified
Officers 4 current
Group structure 1 subsidiary
Controlled by NORTHEDGE CAPITAL NOMINEE LIMITED — since 2023-10-12
From persons-with-significant-control filings on the public register.
Among its peers
Top 5%
by shareholders' funds, of 162 similar companies in ML
The largest employer among its local peers (108 staff).
Trading since 2023.
Competitors Hamilton
This company ranks 2 among other professional, scientific and technical activities not elsewhere classified in Hamilton.